首页 | 本学科首页   官方微博 | 高级检索  
   检索      

GⅡ.17型诺如病毒样颗粒的制备及鉴定
引用本文:王竹叶,韩雪英,王国川,黄克,李娜,姚伦广,刘阳坤.GⅡ.17型诺如病毒样颗粒的制备及鉴定[J].微生物学通报,2022,49(2):483-491.
作者姓名:王竹叶  韩雪英  王国川  黄克  李娜  姚伦广  刘阳坤
作者单位:南阳师范学院生命科学与农业工程学院 河南省畜禽保健品工程技术中心, 河南 南阳 473061;西北农林科技大学动物医学院, 陕西 杨凌 712100
基金项目:国家自然科学基金(31870917,32002302);河南省高等学校重点科研项目(19A230002);河南省科技攻关项目(202102110097,182102310077);河南省“疫苗工程”高校科技创新团队项目(20IRTSTHN024);南阳师范学院高层次人才启动专项(2017ZX012)
摘    要:背景]诺如病毒(Norovirus,NoV)是引发全球人类急性胃肠炎的主要食源性致病原,具有广泛的遗传多样性,其中GⅡ.17型是亚洲地区的优势流行株,危害最为严重。研究表明,通过基因工程技术制备的诺如病毒样颗粒(virus-like particle,VLP)具有良好的免疫保护作用,是目前NoV疫苗研发的主要思路。目的]利用大肠杆菌(Escherichia coli)原核表达系统制备GⅡ.17型诺如病毒的VLP,为GⅡ.17型NoV疫苗的研发奠定基础。方法]合成GⅡ.17型NoV衣壳蛋白VP1的基因并克隆入pET28a-MsyB原核表达质粒中,将重组质粒转化大肠杆菌BL21(DE3)中进行表达,通过烟草蚀纹病毒(tobacco etch virus,TEV)蛋白酶去除融合标签,利用His-Tag镍柱纯化获得天然VP1蛋白,利用SDS-PAGE、Western Blot和透射电镜对纯化后的VP1蛋白反应原性及其形成的结构进行初步鉴定。结果]MsyB-VP1融合蛋白能够以可溶形式大量表达,其最适表达条件为:IPTG浓度0.8 mmol/L,37℃诱导8 h;TEV蛋白酶酶切后的VP...

关 键 词:诺如病毒  GⅡ.17型  病毒样颗粒  原核表达
收稿时间:2021/7/30 0:00:00
修稿时间:2021/10/10 0:00:00

Preparation and identification of Norovirus GⅡ.17 virus-like particles
WANG Zhuye,HAN Xueying,WANG Guochuan,HUANG Ke,LI N,YAO Lunguang,LIU Yangkun.Preparation and identification of Norovirus GⅡ.17 virus-like particles[J].Microbiology,2022,49(2):483-491.
Authors:WANG Zhuye  HAN Xueying  WANG Guochuan  HUANG Ke  LI N  YAO Lunguang  LIU Yangkun
Institution:Henan Provincial Engineering and Technology Center of Health Products for Livestock and Poultry, College of Life Science and Agricultural Engineering, Nanyang Normal University, Nanyang 473061, Henan, China;College of Veterinary Medicine, Northwest A&F University, Yangling 712100, Shaanxi, China
Abstract:Background]Norovirus,featuring genetic diversity,is a major foodborne initiator of acute gastroenteritis in human worldwide.GⅡ.17,the most destructive genotype,is a novel variant emerging in Asia from 2014 through 2015 and has been predominant in Asia.Virus-like particles(VLPs)of Norovirus,prepared by genetic engineering,are safe with high immunogenicity,which are promising candidate vaccine of Norovirus.Objective]This paper aims to prepare GⅡ.17 VLPs in Escherichia coli.Methods]The gene encoding GⅡ.17 capsid protein VP1 was synthesized and cloned into pET28 a-MsyB vector.The recombinant plasmid was transformed into E.coli BL21(DE3)and expressed under the induction of IPTG.The fusion tags were removed by tobacco etch virus(TEV)protease,followed by purification with His-Tag nickel column to yield the natural VP1 protein.SDS-PAGE,Western Blot,and transmission electron microscope were employed to determine the reactogenicity and structure of VP1 protein.Results]MsyB-VP1 can be expressed in soluble form,and the optimum conditions are as follows:IPTG at 0.8 mmol/L,and 37°C for 8 h.The purified VP1 protein digested by TEV protease can specifically bind to mouse anti-GⅡ.17 VP1 polyclonal antibody and assemble into VLPs(diameter:about 40 nm).Conclusion]In this study,GⅡ.17 VLPs were prepared with E.coli,which can be used as the candidate GⅡ.17 vaccine.
Keywords:Norovirus  GⅡ  17  virus-like particle  prokaryotic expression
本文献已被 维普 等数据库收录!
点击此处可从《微生物学通报》浏览原始摘要信息
点击此处可从《微生物学通报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号